Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

MARCAINE HYDROCHLORIDE W/ EPINEPHRINE

BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Standard Dose
0.5%;0.0091MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MARCAINE HYDROCHLORIDE W/ EPINEPHRINE is listed in Drugs@FDA under application 016964 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE Form and strength INJECTABLE;INJECTION - 0.5%;0.0091MG/ML Sponsor HOSPIRA Submission history Latest submission status date: 2020-08-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview MARCAINE HYDROCHLORIDE W/ EPINEPHRINE is listed in Drugs@FDA under application 016964 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE Form and strength INJECTABLE;INJECTION - 0.5%;0.0091MG/ML Sponsor HOSPIRA Submission history Latest submission status date: 2020-08-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE (BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE) | Drug Monograph | MedicHelpline